Itoprom

Itopride Hydrochloride, the active ingredient in Itoprom, is a prokinetic presented as a tablet for oral use. It enhances gastrointestinal motility and is used to relieve symptoms of functional dyspepsia, gastro‑oesophageal reflux disease and other motility disorders in adults. GNH USA supplies Itoprom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Itoprom is a prokinetic agent that acts on gastrointestinal motility disorders. - Functional dyspepsia: improves upper‑abdominal discomfort and early satiety by accelerating gastric emptying. - Gastro‑oesophageal reflux disease (GERD): reduces reflux episodes through enhanced oesophageal clearance. - Gastrointestinal motility disorders: restores coordinated intestinal movement, alleviating bloating and irregular bowel habits.

Adverse reactions may occur with any prokinetic therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate feeling of queasiness. - Diarrhea: loose stools occurring intermittently. - Abdominal pain: cramping or discomfort in the stomach area. - Headache: transient mild to moderate pain. - Dry mouth: reduced salivation. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or tremor. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Elevated liver enzymes: indication of hepatic stress. - Cardiac arrhythmia: irregular heart rhythm. - Neutropenia: reduced white blood cell count. - Anaphylactic shock: life‑threatening systemic reaction.

Before initiating therapy, certain safety considerations are recommended. - Pregnancy: consult a physician; benefits must outweigh potential risks. - Breastfeeding: use with caution; monitor infant for adverse effects. - Renal impairment: dose adjustment may be required based on renal function. - Elderly patients: monitor closely for increased sensitivity to side effects. - Drug interactions: review all concomitant medications for potential interactions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Itoprom may interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): may diminish prokinetic activity and increase dopaminergic imbalance. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise plasma concentrations, heightening adverse effects. - Concurrent prokinetics (e.g., metoclopramide): risk of additive gastrointestinal stimulation and neurological side effects.

Moderate Interactions (Monitor Closely): - Antacids: may reduce absorption; separate administration by at least 2 hours. - Macrolide antibiotics (e.g., erythromycin): potential synergistic increase in gut motility. - Warfarin: monitor INR values for possible anticoagulant effect alteration. - Diuretics: watch electrolyte balance, especially potassium, due to enhanced GI loss.